My Orders
Wishlist
Help
Sell On Loot
Biotechnology Valuation (Electronic book text)
Karl Keegan* The first book to provide a simple and practical means of valuing biotech companies
* The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips
* It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US
* Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them
* The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips
* It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US
* Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them
Not available
Add to wish listReview this Item
Product Description
* The first book to provide a simple and practical means of valuing biotech companies
* The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips
* It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US
* Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them
* The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips
* It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US
* Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them
Customer Reviews
No reviews or ratings yet - be the first to create one!
Product Details
General
Imprint | Wiley |
Country of origin | United States |
Series | Wiley Finance |
Release date | 2009 |
Availability | We don't currently have any sources for this product. If you add this item to your wish list we will let you know when it becomes available. |
Authors | Karl Keegan |
Format | Electronic book text |
Pages | 206 |
ISBN-13 | 978-1-282-34938-4 |
Barcode | 9781282349384 |
Categories | |
LSN | 1-282-34938-4 |
Similar Products | Recommended ProductsSee more 
Trending On Loot
Be the first to know about our
latest deals & promos! Subscribe Now
